ERBB2 and cancer: Various EGFR-and ERBB2-CAR-T clinical trials are also under evaluation for patients with various cancer types (ClinicalTrials.gov Identifier: NCT03618381, NCT03638167, NCT03696030, NCT03198052, etc.).